Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma
{{output}}
Resistance to lenvatinib remains a major barrier in the treatment of advanced hepatocellular carcinoma (HCC), underscoring the urgent need to elucidate the underlying mechanisms and identify actionable therapeutic targets. In this study, we identified a neuros... ...
